Patient-derived stem cell therapy trial for geographic atrophy launches

A clinical trial testing the safety of a patient-specific stem cell-based therapy for the treatment of geographic atrophy has been launched by the National Institutes of Health, according to a press release.
National Eye Institute researchers will convert a patient’s blood cells into induced pluripotent stem cells, which can potentially transform into any type of cell in the body, and program them to become retinal pigment epithelial cells, the release said. The cells will be grown in sheets that are one cell thick, replicating the structure within the eye, before (Read more...)

Full Story →